These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8856122)

  • 21. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
    Bachetti T; Comini L; Pasini E; Cargnoni A; Curello S; Ferrari R
    J Mol Cell Cardiol; 2001 Mar; 33(3):395-403. PubMed ID: 11181009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular catabolism of bradykinin in the isolated perfused rat kidney.
    Bagaté K; Develioglu L; Grima M; De Jong W; Simmons WH; Imbs JL; Barthelmebs M
    Eur J Pharmacol; 2000 Nov; 407(3):317-25. PubMed ID: 11068029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
    Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
    Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.
    Mukae S; Itoh S; Aoki S; Iwata T; Nishio K; Sato R; Katagiri T
    J Hum Hypertens; 2002 Dec; 16(12):857-63. PubMed ID: 12522467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K; Andersson RG
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
    Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
    Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradykinin potentiation by ACE inhibitors: a matter of metabolism.
    Tom B; Dendorfer A; de Vries R; Saxena PR; Jan Danser AH
    Br J Pharmacol; 2002 Sep; 137(2):276-84. PubMed ID: 12208785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of bradykinin in the neonatal renal effects of angiotensin converting enzyme inhibition.
    Tóth-Heyn P; Mosig D; Guignard JP
    Life Sci; 1998; 62(4):309-18. PubMed ID: 9450502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
    Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
    Endlich K; Steinhausen M
    J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
    Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
    J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
    Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
    Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
    Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
    Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
    Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.
    Erdös EG; Jackman HL; Brovkovych V; Tan F; Deddish PA
    J Mol Cell Cardiol; 2002 Dec; 34(12):1569-76. PubMed ID: 12505055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial responses to bradykinin after ramipril therapy in experimental hypertension.
    Hutri-Kähönen N; Pörsti I; Wu X; Tolvanen JP; Sallinen K; Kähönen M
    Pharmacol Toxicol; 1997 Oct; 81(4):190-6. PubMed ID: 9353850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.